Central Nervous System (CNS) therapeutics Market Research Reports
Title | published | price | |
---|---|---|---|
Bipolar Disorder (Manic Depression) (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... r />
The report provides comprehensive information on the therapeutics under development for Bipolar Disorder (Manic Depression), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (......" | 30-Apr-2021 | $2000 | |
Essential Tremor (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... on the therapeutics under development for Essential Tremor, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacologic......" | 30-Apr-2021 | $2000 | |
Chronic Traumatic Encephalopathy (CTE) (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... dscape.
The report provides comprehensive information on the therapeutics under development for Chronic Traumatic Encephalopathy (CTE), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Admi......" | 30-Apr-2021 | $2000 | |
Demyelinating Diseases (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... ensive information on the therapeutics under development for Demyelinating Diseases, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the d......" | 30-Apr-2021 | $2000 | |
Cerebral Infarction (Brain Infarction) (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... dscape.
The report provides comprehensive information on the therapeutics under development for Cerebral Infarction (Brain Infarction), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Admi......" | 30-Apr-2021 | $2000 | |
Vascular Dementias (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... mation on the therapeutics under development for Vascular Dementias, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharm......" | 30-Apr-2021 | $2000 | |
Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... e (Myalgic Encephalomyelitis) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Chronic Fatigue Syndrome (Myalgic Encephalomyelitis), complete with analysis by Stage of Developmen......" | 30-Apr-2021 | $2000 | |
Chronic Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... ides comprehensive information on the therapeutics under development for Chronic Spinal Cord Injury, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report a......" | 30-Apr-2021 | $2000 | |
Back Pain (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... under development for Back Pain, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutic......" | 30-Apr-2021 | $2000 | |
Delirium (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... er development for Delirium, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, i......" | 30-Apr-2021 | $2000 | |
|